Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Gin, US
Aaron Gin, Albuquerque, NM US
| Patent application number | Description | Published |
|---|---|---|
| 20090045395 | Strained-Layer Superlattice Focal Plane Array Having a Planar Structure - An infrared focal plane array (FPA) is disclosed which utilizes a strained-layer superlattice (SLS) formed of alternating layers of InAs and In | 02-19-2009 |
David Gin, Pelham, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20110071097 | CEPHALOTAXUS ESTERS, METHODS OF SYNTHESIS, AND USES THEREOF - The present invention provides novel cephalotaxus esters, syntheses thereof, and intermediates thereto. The invention also provides pharmaceutical compositions comprising a compound of the present invention and methods of using said compounds or compositions in the treatment of proliferative diseases (e.g., benign neoplasm, cancer, inflammatory disease, autoimmune disease, diabetic retinopathy) and infectious disease. The invention further provides methods of using said compounds or compositions in the treatment of multidrug resistant cancer. | 03-24-2011 |
David Gin, New York, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20110300177 | TRITERPENE SAPONINS, METHODS OF SYNTHESIS, AND USES THEREOF - The present invention relates to triterpene glycoside saponin-derived adjuvants, syntheses thereof, intermediates thereto, and uses thereof. QS-7 is a potent immuno-adjuvant that is significantly less toxic than QS-21, a related saponin that is currently the favored adjuvant in anticancer and antiviral vaccines. Tedious isolation and purification protocols have hindered the clinical development of QS-7. A novel semi-synthetic method is provided wherein a hydrolyzed prosapogenin mixture is used to synthesize QS-7, QS-21, and related analogs, greatly facilitating access to QS-7 and QS-21 analogs for preclinical and clinical evaluation. | 12-08-2011 |
Douglas Gin, Longmont, CO US
| Patent application number | Description | Published |
|---|---|---|
| 20080296305 | Fluid Storage and Purification Method and System - A method and device for storing and dispensing a fluid includes providing a vessel configured for selective dispensing of the fluid therefrom. Provided within a vessel is a nancomposite material comprising an imidazolium surfactant and an integral solvent that is essential to the formation of the nancomposite material. The fluid is contacted with the nanocomposite material for take-up of the fluid by the polymerized nanocomposite material. The fluid is released from the nanocomposite material and dispensed from the vessel. | 12-04-2008 |
Douglas L. Gin, Longmont, CO US
| Patent application number | Description | Published |
|---|---|---|
| 20080319202 | FLUID STORAGE AND DISPENSING METHODS AND APPARATUS - A method and device for storing and dispensing a fluid includes providing a vessel configured for selective dispensing of the fluid therefrom. Provided within a vessel is a nanocomposite material comprising an imidazolium surfactant and an integral solvent that is essential to the formation of the nanocomposite material. The fluid is contacted with the nanocomposite material for take-up of the fluid by the polymerized nanocomposite material. The fluid is released from the nanocomposite material and dispensed from the vessel. | 12-25-2008 |
| 20090171098 | Heteroaryl Salts and Methods For Producing and Using the Same - The invention provides heteroaryl salts and methods for producing the same. In particular, the invention provides heteroaryl salts of the formula: | 07-02-2009 |
| 20090173693 | LYOTROPIC LIQUID CRYSTAL MEMBRANES BASED ON CROSS-LINKED TYPE I BICONTINUOUS CUBIC PHASES - The invention provides composite nanofiltration membranes with a lyotropic liquid crystal (LLC) polymer composition embedded in or forming a layer on a porous support. The LLC membranes are prepared from LLC monomers which form a bicontinuous cubic (Q | 07-09-2009 |
| 20090291872 | Ionic Liquids and Methods For Using the Same - The present invention provides compositions comprising ionic liquids and an amine compound, and methods for using and producing the same. In some embodiments, the compositions of the invention are useful in reducing the amount of impurities in a fluid medium or a solid substrate. | 11-26-2009 |
| 20090291874 | IONIC LIQUIDS AND METHODS FOR USING THE SAME - The present application discloses compositions comprising ionic liquids and an amine compound, and methods for using and producing the same. In some embodiments, the compositions disclosed herein are useful in reducing the amount of impurities in a fluid medium or a solid substrate. | 11-26-2009 |
| 20100096327 | POLYMER COATINGS THAT RESIST ADSORPTION OF PROTEINS - The invention provides membranes useful for filtration of water and other liquids. The membrane may be a composite membrane having a polymer layer incorporating quaternary phosphonium or ammonium groups. The polymer layer may be resistant to protein adsorption in an aqueous environment. The membrane may also be a surface-modified membrane in which a polymer having quaternary phosphonium or ammonium groups is covalently attached to the membrane surface. Methods for making and using the membranes of the invention are also provided. | 04-22-2010 |
Jerry G. Gin US
| Patent application number | Description | Published |
|---|---|---|
| 20100035992 | Methods and Compositions for Treating Inflammation and Inflammation-Related Pathologies - Methods and compositions are provided for the treatment of inflammation and disorders, diseases, and adverse conditions, i.e., pathologies, caused by or otherwise associated with inflammatory processes. A metal ion sequestering agent that directly or indirectly exerts an anti-inflammatory effect is administered to a subject in combination with a sequestration inactivating moiety that facilitates transport of the metal ion sequestering agent through biological membranes. The sequestration inactivating moiety also inactivates the metal ion sequestering agent until association between the two components is cleaved in vivo to release the active sequestering agent. Compositions containing a metal ion sequestering agent and a sequestration inactivating moiety are also provided; the compositions optionally contain an added anti-inflammatory agent. | 02-11-2010 |